Physician profile
Aparna Ashok
NPI 1801389713
$5,588.67
in general payments reported to CMS, 2019-2025
17 companies · $2,090 in 2025
The $2,090 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.84 · 2023: $2,016 · 2024: $1,466 · 2025: $2,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,000 · Food and Beverage: $2,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,000.12 |
| Food and Beverage | $2,571.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,356.24 | 2023-2025 | Solyx Sis System, Ams 700, Axonics |
| Coloplast Corp | $1,727.29 | 2023-2025 | Altis |
| Histosonics, INC. | $159.60 | 2024-2025 | |
| Photocure INC | $78.67 | 2025 | Cysview |
| Novartis Pharmaceuticals Corporation | $30.60 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $29.40 | 2024 | Bard Urinary Drainage Bag |
| Innovation Technologies INC | $24.43 | 2024 | Irrisept |
| Endo USA, INC. | $24.38 | 2025 | Xiaflex |
| Ambu INC. | $23.76 | 2025 | |
| Sumitomo Pharma America, INC. | $23.04 | 2025 | Orgovyx |
| Ferring Pharmaceuticals INC. | $21.27 | 2025 | Adstiladrin |
| Abbvie INC. | $17.13 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.84 | 2019 | |
| Cycle Pharmaceuticals INC | $16.27 | 2025 | Venxxiva |
| Integra Lifesciences Corporation | $14.49 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $12.88 | 2024 | Ecoin Device Kit |
| Laborie Medical Technologies Corp. | $12.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aparna Ashok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.